Research Article
Increased Serum Angiotensin II Is a Risk Factor of Nonalcoholic Fatty Liver Disease: A Prospective Pilot Study
Table 3
Clinical and laboratory characteristics of the study patients divided into two groups according to the FibroScan Cap value.
| Variables | FibroScan Cap () | FibroScan Cap () | value |
| Age (years) | | | 0.872 | Gender (male, %) | 33, 78.57% | 28, 87.50% | 0.371 | Body weight (kg) | | | <0.001 | BMI value | | | 0.003 | ALT (U/L) | | | 0.074 | AST (U/L) | | | 0.374 | Albumin (g/L) | | | 0.036 | CRP (mg/L) | | | 0.198 | TG (mmol/L) | | | 0.314 | CHOL (mmol/L) | | | 0.230 | HDL (mmol/L) | | | 0.094 | LDL (mmol/L) | | | 0.107 | VLDL (mmol/L) | | | 0.377 | FBG (mmol/L) | | | 0.165 | Serum insulin (mIU/L) | | | 0.007 | HOMA-IR | | | 0.016 | Ang II (pg/mL) | | | 0.040 | PRA (pg/mL) | | | 0.427 | ALD (pg/mL) | | | 0.312 | PRA/ALD | | | 0.577 | IL-18 (pg/mL) | | | 0.343 | IL-1β (pg/mL) | | | 0.339 |
|
|